Aneurysm Treatment <24 Versus h After Subarachnoid Hemorrhage
|
|
- Abel Sanders
- 6 years ago
- Views:
Transcription
1 Neurocrit Care (2014) 21:4 13 DOI /s ORIGINAL ARTICLE Aneurysm Treatment <24 Versus h After Subarachnoid Hemorrhage Simone C. Oudshoorn Gabriel J. E. Rinkel Andrew J. Molyneux Richard S. Kerr Sanne M. Dorhout Mees Daan Backes Ale Algra Mervyn D. I. Vergouwen Published online: 18 March 2014 Ó Springer Science+Business Media New York 2014 Abstract Introduction In patients with aneurysmal subarachnoid hemorrhage (asah), it is unclear whether aneurysm treatment <24 h after ictus results in better outcomes than treatment h after asah. We studied whether aneurysm occlusion <24 h is associated with better outcomes than occlusion h after asah. Methods We used two cohorts of patients with asah: (1) the UMC Utrecht cohort with patients admitted between 2008 and 2012 and (2) the International Subarachnoid Aneurysm Trial cohort. Aneurysm treatment was categorized into <24 h and h after ictus. We calculated adjusted risk ratios (arrs) with 95 % confidence intervals (CIs) using Poisson regression analyses for poor functional outcome (death or dependency) for both cohorts separately, and performed a pooled analysis based on individual patient data. We also performed a worst-case scenario analysis wherein all patients with rebleeding >3 h after admission were re-categorized into the group with aneurysm treatment h after asah. Results We included 1,238 patients (UMC Utrecht cohort: n = 330; ISAT: n = 908). The arr for poor outcome after treatment <24 h was in the UMC Utrecht cohort 1.84 (95 % CI: ), in ISAT 1.14 (95 % CI ), in the pooled analysis 1.37 (95 % CI ), and in the worst-case scenario pooled analysis 1.24 (95 % CI ). Conclusion Our results suggest that aneurysm occlusion can be performed in day time within 72 h after ictus, instead of on an emergency basis. However, due to the retrospective, non-randomized design of our study, our results cannot be considered as definitive evidence. Keywords Subarachnoid hemorrhage Aneurysm Treatment Clipping Coil embolization Timing Introduction S. C. Oudshoorn G. J. E. Rinkel S. M. Dorhout Mees D. Backes A. Algra M. D. I. Vergouwen (&) Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Room G03-228, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands m.d.i.vergouwen@umcutrecht.nl A. J. Molyneux R. S. Kerr Neurovascular Research Unit, Nuffield Department of Surgery, University of Oxford, Oxford, UK A. J. Molyneux R. S. Kerr Oxford Radcliffe Hospitals NHS Trust, John Radcliffe Hospital, Oxford, UK A. Algra Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands Since a pivotal trial in the 1980s found no overall difference in outcome after aneurysmal subarachnoid hemorrhage (asah) between aneurysm treatment within 3 days of rupture versus postponed aneurysm treatment more than 7 days after rupture, timing of aneurysm treatment has shifted from a delayed phase to an early phase within 72 h after ictus [1]. The ESO guidelines recommend aneurysm treatment as early as logistically and technically possible within 72 h after asah to reduce the risk of rebleeding [2]. The guidelines of the American Heart Association recommend aneurysm treatment as early as feasible to reduce the rate of rebleeding (Class I, level of Evidence B) [3]. As a clinical implication, many centers nowadays try to occlude aneurysms on an emergency basis
2 Neurocrit Care (2014) 21: within a couple of hours, also during night time. However, evidence that aneurysm occlusion within 24 h after ictus improves outcome is lacking. Treatment within 24 h may even be detrimental, because processes induced by the initial ischemia from aneurysmal rupture may provoke delayed cerebral ischemia (DCI) [4]. Aneurysm treatment in itself also induces cerebral ischemia [5 9], and may therefore add to the risk of DCI if performed within the initial aneurysm rupture. Moreover, treatment within 24 h is a logistic and economic burden and increases burden on neurosurgeons and interventional neuroradiologists. Our objective was to investigate if aneurysm treatment within 24 h is indeed associated with better functional outcomes than treatment h after ictus. Methods For this observational study, we used two cohorts of patients with aneurysmal asah: patients retrieved from (1) the University Medical Center (UMC) Utrecht SAH database and (2) the International Subarachnoid Aneurysm Trial (ISAT) database. From both cohorts, we extracted the following variables: age, sex, clinical condition according to the World Federation of Neurological Surgeons (WFNS) scale [10], aneurysm location, maximum aneurysm size, timing of aneurysm treatment, modality of aneurysm treatment, occurrence of rebleeding and DCI, and functional outcome. Timing of aneurysm treatment was categorized into <24 h after ictus and h after asah. In the UMC Utrecht cohort, poor functional outcome was defined as a Glasgow Outcome Scale (GOS) score of 1 3 three months after ictus [11]. In ISAT, poor functional outcome was defined as a modified Rankin Scale score of 3 6 two months after asah [12]. UMC Utrecht Cohort The UMC Utrecht SAH database is a prospectively collected database that includes >3,500 consecutive patients with confirmed SAH. For the purpose of this study, we included all patients with asah admitted between January 1, 2008, and January 1, Approval was obtained from the Institutional Research Ethics Board. In the UMC Utrecht cohort, the time interval between ictus and aneurysm treatment was measured in hours. Patients were included if the aneurysm was treated within 72 h after ictus, or if aneurysm treatment was postponed to >72 h after ictus because of rebleeding C3 h after admission (these episodes of rebleeding could have been prevented by prompt aneurysm occlusion), or if patients were admitted in good clinical condition but received no aneurysm treatment because of rebleeding C3 h after admission. Aneurysm treatment included clipping and endovascular treatment. Exclusion criteria were (1) death imminent; (2) untreatable aneurysm; and (3) age <16 years. In the UMC Utrecht, all aneurysms are treated during daytime by experienced vascular neurosurgeons or interventional neuroradiologists. In the UMC Utrecht cohort, the occurrence of rebleeding was recorded between admission and aneurysm treatment, and defined as a sudden clinical deterioration with signs of increased hemorrhage on CT scan compared with previous CT imaging or found at autopsy, or a sudden clinical deterioration suspect for rebleeding with fresh blood in the ventricular drain in which no CT scan or autopsy was obtained. For clinical deterioration due to DCI we used the definition that was recently proposed by an international multidisciplinary research group [13]. Functional outcome 3 months after SAH was typically assessed by a stroke nurse, either during a visit to the outpatient clinic or by telephone interview. ISAT Cohort ISAT is a randomized trial that compared the efficacy of neurosurgical clipping with endovascular coiling in 2,143 patients with asah [12]. Patients were eligible for inclusion in ISAT if there was a confirmed SAH within the previous 28 days, and an aneurysm that was suitable for both neurosurgical clipping and endovascular coiling, but with uncertainty on which treatment was most suitable. Only patients 18 years or older were included. In ISAT, the WFNS score was recorded at time of randomization, the time interval between ictus and aneurysm treatment was measured in days, and the occurrence of rebleeding was recorded between randomization and aneurysm treatment. Patients were included if the aneurysm was treated at day 0 (maximum 24 h after ictus), day 1 or 2 (maximum 72 h after ictus) after ictus, if rebleeding occurred between randomization and aneurysm treatment with treatment beyond day 2, or if rebleeding occurred after randomization and no aneurysm treatment was performed. For the purpose of this study, aneurysm treatment at day 0 was considered <24 h after ictus, and treatment at days 1 or 2 as h after asah. Patients were excluded if no follow-up data were available on either functional outcome or case fatality 2 months after ictus. Modality of aneurysm treatment was defined as the type of aneurysm treatment the patient actually received, also if treatment crossover occurred. In the ISAT manual, clinical deterioration due to DCI was defined as clinical grounds of delayed ischemic neurological deficit, not due to operative factors or other factors such as procedural vessel occlusion, hydrocephalus or aneurysmal rebleeding, and by the clinicians judged to be due to vasospasm [14]. Clinical outcome was assessed by self-reported questionnaires
3 6 Neurocrit Care (2014) 21:4 13 with the modified Rankin Scale score two months after ictus [15]. Outcome Measures Primary outcome was poor functional outcome. Secondary outcomes in the UMC Utrecht cohort were case fatality three months after asah and clinical deterioration due to DCI. Secondary outcomes in the ISAT cohort were case fatality 2 months after asah and clinical deterioration due to DCI. Statistical Analyses First, we performed an on-treatment analysis and compared the primary and secondary outcome measures between the groups of patients with aneurysm treatment <24 h and h after asah. Risk ratios (RR) with 95 % confidence intervals (CI) were calculated with the group of patients treated h after ictus as the reference group. Adjusted risk ratios (arrs) were calculated using Poisson regression analyses with adjustments for the following predefined variables: age, sex, WFNS score, location of aneurysm, maximum aneurysm size, and type of aneurysm treatment. To compare the proportion of patients with DCI in patients with aneurysm treatment <24 h and h after ictus, we calculated arrs with 95 % CIs. For the pooled analyses, adjustments were made for all six predefined variables plus asah cohort. Second, we performed a worst-case scenario analysis for the primary outcome measure. In the UMC Utrecht cohort, we re-categorized all patients with intention of aneurysm treatment who had rebleeding C3 h after admission to the group of patients treated h after admission. This analysis was performed to assure that all patients who had rebleeding within the initial 24 h were analyzed as if the intention was to perform aneurysm treatment in the h interval. For the same reason, we included in the h interval all patients with postponement of aneurysm treatment to >72 h because of rebleeding and patients with no aneurysm treatment because of rebleeding. For ISAT, we re-categorized all patients with intention of aneurysm treatment and rebleeding to the group of patients treated h after asah. For this worst-case scenario analysis, risk ratios were calculated with adjustments for all predefined variables as described previously. Third, we performed a sensitivity analysis for the primary outcome measure in which timing of aneurysm treatment in both cohorts was defined similar to the original categorization in ISAT (treatment at day 0 vs. treatment at days 1 2). Fourth, we performed subgroup analyses for the primary outcome measure for type of aneurysm treatment (clipped or coiled) and for WFNS score. For these subgroup analyses, risk ratios were calculated with adjustments for all predefined variables except for the variable under investigation. For the on-treatment, worst-case scenario, and sensitivity analyses, we first performed the analyses for both cohorts separately, and subsequently a pooled analysis was performed based on individual patient data. For the pooled analyses, we made adjustments not only for the predefined variables, but also for the asah cohort since it was a confounder. Subgroup analyses were performed in the pooled dataset only to avoid small numbers of patients in certain subgroups. Finally, we performed a literature search and metaanalysis of the studies found. We searched Pubmed with the terms subarachnoid hemorrhage AND aneurysm treatment AND ( timing OR 24 h ) AND outcome for publications comparing poor functional outcome (death or dependency) in patients with asah and aneurysm treatment <24 h versus aneurysm treatment >24 h after ictus, regardless of study quality, and language restricted to English, French, German, and Spanish. We calculated crude RR with 95 % CI for individual studies and pooled RRs. Results During the study period, 569 patients with asah were admitted to the UMC Utrecht. For the analyses, we included 330 patients (<24 h: n = 134; h: n = 180; treatment postponed to >72 h because of rebleeding C3 h after admission: n = 4; no aneurysm treatment despite intention to treatment but rebleeding C3 h after admission: n = 12) (Fig. 1). Baseline characteristics of patients treated <24 h and h after ictus are listed in Table 1. Rebleeding before aneurysm occlusion occurred in 14 patients (10 %) with aneurysm treatment <24 h and in 5 patients (3 %) with aneurysm treatment h after ictus. From the ISAT cohort, we included 908 patients (day 0: n = 83; days 1 2: n = 804; beyond day 2: n = 9; no aneurysm treatment because of rebleeding after randomization: n = 12) (Fig. 2). Reasons for exclusion were aneurysm treatment beyond day 2 after asah without rebleeding (n = 1,231) and missing data on outcome (n = 4). Baseline characteristics are listed in Table 1. Rebleeding occurred in 1 patient (1 %) treated at day 0 and in 17 patients (2 %) treated at days 1 2. Data on functional outcome 2 months after ictus were available in 81 patients treated at day 0 and 800 patients treated at days 1 2 after asah. Median number of days from admission to randomization in the included patients was 0 (IQR 0-0).
4 Neurocrit Care (2014) 21: Fig. 1 Flowchart of UMC Utrecht cohort Patients presenting with asah during study period, n=569 Excluded: Death imminent or short life-expectancy, n = 99 Untreatable aneurysm, n = 6 Age <16 years, n = 1 intention to aneurysm treatment, n = 463 Excluded: Good clinical condition on admission, but deterioration <3 admission, n = 8 GOS after three months unknown, n = 2 <24 asah, n = asah, n = 180 >72 asah, n = 127 No aneurysm treatment despite good clinical condition on admission, but admission, n = 12 admission, n = 5 admission, n = 1 admission, n = 4 admission, n = 12 Included in group <24 hours, n = 134 Included in group hours, n = 180 Included in worstcase scenario analysis, n = 4 Included in worstcase scenario analysis, n = 12 On-treatment Analyses Results of the on-treatment analyses are shown in Table 2. Treatment <24 h was not associated with better functional outcome (arr in pooled analysis: 1.37; 95 % CI ) or a reduction in case fatality (arr in pooled analysis: 1.51; 95 % CI ). The arr for clinical deterioration due to DCI after treatment <24 h was in the UMC Utrecht cohort 1.13 (95 % CI ), in ISAT 1.02 (95 % CI ), and in the pooled analysis 1.01 (95 % CI ). Worst-Case Scenario Analysis Accounting for Potentially Preventable Rebleeding Results of the worst-case scenario analyses are shown in Table 2. In the UMC Utrecht cohort, 12 patients with intention to aneurysm treatment had rebleeding C3 h after
5 8 Neurocrit Care (2014) 21:4 13 Table 1 Baseline characteristics, in-hospital complications, and outcomes according to time to treatment UMC Utrecht cohort ISAT cohort Pooled databases 0 24 h h 0 24 h h 0 24 h h N = 134 N = 180 N = 83 N = 804 N = 217 N = 984 Median age (IQR) 55 (47 62) 56 (47 66) 53 (45 60) 51 (42 58) 54 (46 61) 51 (43 59) Females 88 (66) 131 (73) 59 (71) 500 (62) 147 (68) 631 (64) WFNS score on admission 1 (GSC 15) 42 (31) 87 (48) 32 (39) 483 (60) 74 (34) 570 (58) 2 (GCS 13 14) 39 (29) 43 (24) 32 (39) 218 (27) 71 (33) 261 (27) 3 (GCS 13 14) 6 (5) 9 (5) 3 (4) 43 (5) 9 (4) 52 (5) 4 (GCS 7 12) 25 (19) 26 (14) 7 (8) 36 (5) 32 (15) 62 (6) 5 (GCS < 7) 21 (16) 11 (6) 3 (4) 12 (2) 24 (11) 23 (2) Unclear 1 (1) 4 (2) 6 (7) 12 (2) 7 (3) 16 (2) Posterior circulation aneurysm 7 (5) 28 (16) 3 (4) 22 (3 %) 10 (5) 50 (5) Median aneurysm size in mm (IQR) 6 (4 8) 6 (4 8) 6 (4 8) 5 (4 8) 6 (4 8) 6 (4 8) Type of treatment Endovascular 65 (49) 94 (52) 51 (61) 431 (54) 116 (54) 525 (53) Clipping 69 (52) 86 (48) 32 (39) 373 (46) 101 (47) 459 (47) Complications Rebleeding 14 (10) a 5 (3) 1 (1) 17 (2) 15 (7) 22 (2) DCI 37 (28) 36 (20) 22 (27) 195 (24) 59 (27) 231 (24) Poor functional outcome 51 (38) 31 (17) 32/81 (40) 215/800 (27) 83/215 (39) 246/980 (25) Case-fatality 20 (15) 13 (7) 11 (13) 58 (7) 31 (14) 71 (7) Data are number (%) unless indicated otherwise IQR interquartile range, WFNS World Federation of Neurological Surgeons, DCI delayed cerebral ischemia, CT computed tomography a In 5 of these 14 patients rebleeding occurred > 3 h after admission. These 5 patients were in the worst case scenario analysis grouped into the h treatment group admission, and therefore did not receive aneurysm treatment. In addition, five patients with aneurysm treatment <24 h after ictus and four patients with aneurysm treatment >72 h after asah had rebleeding C3 h after admission. If these 21 patients were added to the group of patients with aneurysm treatment h after ictus, the arr for poor outcome after treatment <24 h was 1.50 (95 % CI ). In ISAT, 12 patients had rebleeding after randomization, and therefore no aneurysm treatment was performed. In addition, 9 patients with aneurysm treatment beyond day 2 had rebleeding and 1 patient with aneurysm treatment at day 0. If these 22 patients were added to the group of patients with aneurysm treatment h after ictus, the arr for poor outcome after treatment <24 h was 1.12 (95 % CI ). In the worstcase scenario pooled analysis, the arr for poor outcome after treatment <24 h was 1.24 (95 % CI ). Sensitivity Analysis Results of the sensitivity analyses are shown in Table 2. If time of aneurysm treatment in the UMC Utrecht cohort was categorized in days instead of hours similar to the original categorization in ISAT, 286 patients were included in the UMC Utrecht cohort. The arr for poor outcome after treatment at day 0 in the UMC Utrecht cohort was 1.57 (95 % CI ), and in the pooled analysis was 1.26 ( ). Subgroup Analyses Results of subgroup analyses of pooled cohorts are shown in Fig. 3. Treatment <24 h was not associated with better functional outcome in any subgroup. Meta-analysis of Previous Studies Four recent studies compared functional outcomes in patients treated <24 and >24 h after asah (Table 3) [16 19]. One of these studies performed a subgroup analysis in which patients treated <24 h were compared with those treated 1 3 days after asah [16]. The pooled RR for aneurysm treatment <24 h versus >24 h was 0.76 (95 % CI ) and for aneurysm treatment <24 h versus h was 1.34 ( ) (Fig. 4a, b).
6 Neurocrit Care (2014) 21: Fig. 2 Flowchart of ISAT cohort asah with intention to aneurysm treatment, n = 2143 Excluded: Missing data on outcome, n = 4 at day 0, n = 83 at days 1-2, n = 804 beyond day 2, n = 1240 No aneurysm treatment despite good clinical condition on admission, but rebleeding after randomization, n = 12 rebleeding after randomization, n=1 rebleeding after randomization, n=17 rebleeding after randomization, n=9 admission, n = 12 Included in group <24 hours, n = 83 Included in group hours, n = 804 Included in worstcase scenario analysis, n=9 Included in worstcase scenario analysis, n=12 Table 2 Poor functional outcome and case fatality according to time to treatment UMC Utrecht cohort ISAT cohort Pooled cohorts 0 24 h h a 0 24 h h a 0 24 h h a Poor functional outcome (n/n (%)) 51/134 (38) 31/180 (17) 32/81 (40) 215/800 (27) 83/215 (39) 246/980 (25) Unadjusted risk ratio 2.21 ( ) ( ) ( ) b 1 Adjusted risk ratios On-treatment analysis 1.84 ( ) ( ) ( ) b 1 Worst-case scenario analysis 1.50 ( ) ( ) ( ) b 1 Sensitivity analysis 1.57 ( ) ( ) ( ) b 1 Case-fatality (n/n (%)) 20/134 (15) 13/180 (7) 11/83 (13) 58/804 (7) 31/217 (14) 71/984 (7) Unadjusted risk ratio 2.07 ( ) ( ) ( ) b 1 Adjusted risk ratios On-treatment analysis 1.88 ( ) ( ) ( ) b 1 Data are number (%) or risk ratio (95 % CI) WFNS World Federation of Neurological Surgeons a Reference group b All pooled analyses were (also) adjusted for asah cohort Discussion In two large independent cohorts of asah patients, aneurysm treatment <24 h did not result in better outcomes than treatment h after ictus. This result was robust even if we performed a worst-case scenario analysis accounting for cases of rebleeding that could have been prevented if the aneurysm was treated immediately after
7 10 Neurocrit Care (2014) 21:4 13 Fig. 3 Results of subgroup analyses of pooled cohorts. Adjusted risk ratios with 95 % CI for poor functional outcome. <24 h are compared with those treated h after ictus admission. Also in none of the subgroup analyses was treatment <24 h associated with better functional outcome than treatment h after ictus. The meta-analysis including previous studies shows that aneurysm treatment <24 h SAH is better than treatment >24 h, but not h after ictus. One study investigated the relationship between timing of aneurysm treatment and rebleeding and did not find such a relationship [17]. In contrast with two previous studies suggesting that aneurysm treatment <24 h is associated with better outcomes [16, 19], we did not include patients treated >72 h after ictus, since delayed treatment beyond 72 h mostly results from late admission, logistic problems, or complex aneurysm characteristics, and therefore should not be combined with that of patients treated within 72 h. In the subgroup analysis that found a statistically non-significant reduction in poor outcome in patients treated <24 h versus those treated h after asah, no adjustments were made for baseline characteristics [16]. Neither previous study performed a worst-case scenario analysis as we did, to account for the rebleeding that might have resulted in postponement or cancellation of aneurysm treatment [16, 17, 19]. Despite the theoretical advantage of preventing episodes of rebleeding by emergency aneurysm occlusion, we found no improved outcome from aneurysm treatment <24 h, but a worse outcome instead. A first explanation for lack of effectiveness of aneurysm treatment <24 h is that many instances of rebleeding occur soon after admission. Indeed, in the UMC Utrecht cohort, two-thirds of episodes of rebleeding occurred within 3 h after admission. It will be almost impossible to perform aneurysm occlusion within this time frame. Moreover, the beneficial effect of aneurysm treatment <24 h on prevention of rebleeding may be offset by impeded recovery from early brain injury after asah. In recent years, there is increased interest in early brain injury after asah resulting from increased intracranial pressure, microvascular alterations, platelet aggregation, acute vasospasm, and reperfusion injury [20 24]. These factors may contribute to the finding of a worse outcome in the <24 h aneurysm treatment group. The strength of our study is that we investigated two cohorts of asah patients, in which functional outcome was collected prospectively and blinded for the present research question. In the UMC Utrecht cohort, loss to follow-up was less than 1 %. We performed regression analyses and a worst-case scenario analysis to account for rebleeding which did not change our conclusions. We were also able to perform pooled analyses based on individual patient data. A limitation of our study is that it was a retrospective, non-randomized comparison. As a result, no proper intention-to-treat analysis could be performed. However, the
8 Neurocrit Care (2014) 21: Table 3 Overview of studies comparing outcomes in patients with aneurysm treatment <24 h versus >24 h after ictus Study N a Comparison of timing of aneurysm treatment in hours Number of patients with poor outcome (n/n (%)) b Crude risk ratio (95 % CI) Phillips et al. [16] 408 <24 versus >24 h <24 h: 16/199 (8 %) 0.56 ( ) >24 h: 30/209 (14 %) 382 <24 versus h <24 h: 16/199 (8 %) 0.64 ( ) h: 23/183 (13 %) Wong et al. [17] 276 <24 versus >24 h <24 h: 54/148 (36 %) 0.90 ( ) >24 h: 52/128 (41 %) Sandström et al. [18] 122 <24 versus >24 h <24 h: 33/80 (41 %) 0.87 ( ) >24 h: 20/42 (48 %) Gu et al. [19] 96 <24 versus >24 h <24 h: 7/56 (13 %) 0.42 ( ) >24 h: 12/40 (30 %) Oudshoorn et al. 314 <24 versus h <24 h: 51/134 (38 %) 2.21 ( ) (UMCU) h: 31/180 (17 %) 881 <24 versus h <24 h: 32/81 (40 %) 1.47 ( ) (ISAT) h: 215/800 (27 %) mrs modified Rankin scale score, CI confidence interval a Total number of patients with available outcomes b Defined as modified Rankin scale score of 3 6 or GOS score of 1 3 A Study or Subgroup Treatment <24 h Events Total Treatment >24 h Events Total Weight Risk Ratio M-H, Fixed, 95% CI Year Risk Ratio M-H, Fixed, 95% CI Phillips 2011 Wong 2012 Gu 2012 Sandström % 44.5% 11.2% 20.9% 0.56 [0.32, 1.00] 0.90 [0.67, 1.21] 0.42 [0.18, 0.96] 0.87 [0.57, 1.31] Total (95% CI) % 0.76 [0.61, 0.94] Total events Heterogeneity: Chi² = 4.66, df = 3 (P = 0.20); I² = 36% Test for overall effect: Z = 2.48 (P = 0.01) Favours treatment <24 h Favours treatment >24 h B Study or Subgroup Treatment <24 h Events Total Treatment h Events Total Weight Risk Ratio M-H, Random, 95% CI Year Risk Ratio M-H, Random, 95% CI Phillips 2011 Oudshoorn 2014 UMCU Oudshoorn 2014 ISAT % 34.7% 37.2% 0.64 [0.35, 1.17] [1.50, 3.25] [1.10, 1.97] 2014 Total (95% CI) % 1.34 [0.76, 2.37] Total events Heterogeneity: Tau² = 0.20; Chi² = 11.54, df = 2 (P = 0.003); I² = 83% Test for overall effect: Z = 1.01 (P = 0.31) Favours treatment 24 h Favours treatment h Fig. 4 a Pooled (crude) relative risk estimates for poor functional outcome for patients with aneurysm treatment <24 h versus >24 h after ictus. b Pooled (crude) relative risk estimates for poor functional outcome for patients with aneurysm treatment <24 h versus h after ictus worst-case scenario analysis, where we regrouped all patients with rebleeding >3 h after admission into the h treatment group to simulate a worst-case intention-to-treat analysis, did not change the results essentially. The non-randomized design may have resulted in baseline differences between the groups, because the decision to treat the aneurysm <24 h or h after ictus may have been influenced by the clinical condition of the patient. Although we performed regression analyses with adjustments for variables such as WFNS score and aneurysm size and location, and performed subgroup analyses for WFNS score which did not change our findings, it could be that
9 12 Neurocrit Care (2014) 21:4 13 there were other factors that we did not account for. Another limitation is that definitions in ISAT were somewhat different than in the UMC Utrecht cohort. In ISAT, day of aneurysm treatment was expressed in days after asah, with day of ictus defined as day 0. As a result, treatment at day 1 also included patients who were treated within 24 h after asah. To account for differences in definition, we performed a sensitivity analysis using the ISAT definition in both cohorts, which did not change the results essentially. In addition, in ISAT, rebleeding was defined as recurrent bleeding between randomization and treatment. Therefore, cases with rebleeding between admission and randomization were not included in this analysis, which explains the lower incidence of rebleeding in ISAT compared with the UMC Utrecht cohort. Our results suggest that in clinical practice, aneurysm occlusion can be performed in day time within 72 h after ictus, instead of on an emergency basis. However, due to the retrospective, non-randomized design, our results are no sound evidence for either strategy. Such evidence should preferably come from a randomized trial comparing aneurysm treatment <24 h versus treatment h after ictus, but the feasibility of such a trial is questionable. Acknowledgments Funding None. None. Conflict of interest Andrew Molyneux reports a consulting agreement with Sequent Medical Inc. All other authors have no conflicts of interest. References 1. Ohman J, Heiskanen O. Timing of operation for ruptured supratentorial aneurysms: a prospective randomized study. J Neurosurg. 1989;70: Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G, European Stroke Organization. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35: Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, American Heart Association Stroke Council, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43: Brilstra EH, Rinkel GJ, Algra A, van Gijn J. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology. 2000;55: Cronqvist M, Wirestam R, Ramgren B, Brandt L, Nilsson O, Saveland H, et al. Diffusion and perfusion MRI in patients with ruptured and unruptured intracranial aneurysms treated by endovascular coiling: complications, procedural results, MR findings and clinical outcome. J Neuroradiol. 2005;47: Grunwald IQ, Papanagiotou P, Politi M, Struffert T, Roth C, Reith W. Endovascular treatment of unruptured intracranial aneurysms: occurrence of thromboembolic events. J Neurosurg. 2006;58: Hahnemann ML, Ringelstein A, Sandalcioglu IE, Goericke S, Moenninghoff C, Wanke I, et al. Silent embolism after stentassisted coiling of cerebral aneurysms: diffusion-weighted MRI study of 75 cases. J Neurointerv Surg. 2013;. doi: / neurintsurg Kang DH, Kim BM, Kim DJ, Suh SH, Kim DI, Kim YS, et al. MR-DWI-positive lesions and symptomatic ischemic complications after coiling of unruptured intracranial aneurysms. Stroke. 2013;44: Soeda A, Sakai N, Murao K, Sakai H, Ihara K, Yamada N, et al. Thromboembolic events associated with Guglielmi detachable coil embolization with use of diffusion-weighted MR imaging. Part II. Detection of the microemboli proximal to cerebral aneurysm. AJNR Am J Neuroradiol. 2003;24: Teasdale GM, Drake CG, Hunt W, Kassell N, Sano K, Pertuiset B, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry. 1988;51: Jennett B, Teasdale G, Braakman R, Minderhoud J, Knill-Jones R. Predicting outcome in individual patients after severe head injury. Lancet. 1976;1: Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360: Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41: Dorhout Mees SM, Kerr RS, Rinkel GJ, Algra A, Molyneux AJ. Occurrence and impact of delayed cerebral ischemia after coiling and after clipping in the International Subarachnoid Aneurysm Trial (ISAT). J Neurol. 2012;259: van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19: Phillips TJ, Dowling RJ, Yan B, Laidlaw JD, Mitchell PJ. Does treatment of ruptured intracranial aneurysms within 24 hours improve clinical outcome? Stroke. 2011;42: Wong GK, Boet R, Ng SC, Chan MT, Gin T, Zee B, et al. Ultraearly (within 24 hours) aneurysm treatment after subarachnoid hemorrhage. World Neurosurg. 2012;77: Sandström N, Yan B, Dowling R, Laidlaw J, Mitchell P. Comparison of microsurgery and endovascular treatment on clinical outcome following poor-grade subarachnoid hemorrhage. J Clin Neurosci. 2013;20: Gu DQ, Zhang X, Luo B, Long XA, Duan CZ. Impact of ultraearly coiling on clinical outcome after aneurysmal subarachnoid hemorrhage in elderly patients. Acad Radiol. 2012;19: Sehba FA, Hou J, Pluta RM, Zhang JH. The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol. 2012;97: Sehba FA, Mostafa G, Knopman J, Friedrich V Jr, Bederson JB. Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg. 2004;101: Sehba FA, Mostafa G, Friedrich V Jr, Bederson JB. Acute microvascular platelet aggregation after subarachnoid hemorrhage. J Neurosurg. 2005;102:
10 Neurocrit Care (2014) 21: Bederson JB, Levy AL, Ding WH, Kahn R, DiPerna CA, Jenkins AL III, et al. Acute vasoconstriction after subarachnoid hemorrhage. J Neurosurg. 1998;42: Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke. 2002;33:
Received: 15 September 2014 /Accepted: 20 November 2014 /Published online: 6 December 2014 # Springer-Verlag Berlin Heidelberg 2014
Neuroradiology (2015) 57:269 274 DOI 10.1007/s00234-014-1472-6 DIAGNOSTIC NEURORADIOLOGY Quantification of structural cerebral abnormalities on MRI 18 months after aneurysmal subarachnoid hemorrhage in
More information(aneurysmal subarachnoid hemorrhage, 17%~60% :SAH. ,asah , 22%~49% : Willis. :1927 Moniz ;(3) 2. ischemic neurological deficit,dind) SAH) SAH ;(6)
,, 2. : ;,, :(1), (delayed ;(2) ischemic neurological deficit,dind) ;(3) 2. :SAH ;(4) 5-10 10 HT -1-1 ;(5), 10 SAH ;(6) - - 27%~50%, ( cerebral vasospasm ) Glasgow (Glasgow Coma Scale,GCS), [1],, (aneurysmal
More informationEpidemiology And Treatment Of Cerebral Aneurysms At An Australian Tertiary Level Hospital
ISPUB.COM The Internet Journal of Neurosurgery Volume 9 Number 2 Epidemiology And Treatment Of Cerebral Aneurysms At An Australian Tertiary Level Hospital A Granger, R Laherty Citation A Granger, R Laherty.
More informationEffectiveness of Diagnostic Strategies in Suspected Delayed Cerebral Ischemia A Decision Analysis
Effectiveness of Diagnostic Strategies in Suspected Delayed Cerebral Ischemia A Decision Analysis Sapna Rawal, MD; Carolina Barnett, MD; Ava John-Baptiste, PhD; Hla-Hla Thein, MD, MPH, PhD; Timo Krings,
More informationTime-Dependent Test Characteristics of Head Computed Tomography in Patients Suspected of Nontraumatic Subarachnoid Hemorrhage
Time-Dependent Test Characteristics of Head Computed Tomography in Patients Suspected of Nontraumatic Subarachnoid Hemorrhage Daan Backes, MSc; Gabriel J.E. Rinkel, MD; Hans Kemperman, PhD; Francisca H.H.
More informationNeurosurgical decision making in structural lesions causing stroke. Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery)
Neurosurgical decision making in structural lesions causing stroke Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery) Subarachnoid Hemorrhage Every year, an estimated 30,000 people in the United States experience
More informationClinic of Geriatrics, Faculty of Health Sciences, Collegium Medicum, Nicolaus Copernicus University, Toruń, Poland 3
Original papers Application of the functional capacity scale in the early assessment of functional efficiency in patients after aneurysm embolization: Preliminary reports Robert Ślusarz 1, A D, F, Monika
More informationEndovascular treatment of intracranial aneurysms by coiling
Long-Term Recurrent Subarachnoid Hemorrhage After Adequate Coiling Versus Clipping of Ruptured Intracranial Aneurysms Joanna D. Schaafsma, MD; Marieke E. Sprengers, MD; Willem Jan van Rooij, MD, PhD; Menno
More informationNIH Public Access Author Manuscript J Am Coll Radiol. Author manuscript; available in PMC 2013 June 24.
NIH Public Access Author Manuscript Published in final edited form as: J Am Coll Radiol. 2010 January ; 7(1): 73 76. doi:10.1016/j.jacr.2009.06.015. Cerebral Aneurysms Janet C. Miller, DPhil, Joshua A.
More informationIntracranial aneurysms are an important health problem
ORIGINAL RESEARCH E.G. Klompenhouwer J.T.A. Dings R.J. van Oostenbrugge S. Oei J.T. Wilmink W.H. van Zwam Single-Center Experience of Surgical and Endovascular Treatment of Ruptured Intracranial Aneurysms
More informationLong term follow-up of patients with coiled intracranial aneurysms Sprengers, M.E.S.
UvA-DARE (Digital Academic Repository) Long term follow-up of patients with coiled intracranial aneurysms Sprengers, M.E.S. Link to publication Citation for published version (APA): Sprengers, M. E. S.
More informationSummary of some of the landmark articles:
Summary of some of the landmark articles: The significance of unruptured intracranial saccular aneurysms: Weibers et al Mayo clinic. 1987 1. 131 patients with 161 aneurysms were followed up at until death,
More informationMethod Hannah Shotton
#asah Method Hannah Shotton 2 Introduction SAH Rupturing aneurysm Poor outlook Intervention Secure the aneurysm: clipping or coiling Recommended 48 hours Regional Specialist NSC Conservative management
More informationPosition Statement. Enrollment and Randomization. ISAT Study Design. ISAT Results
Position Statement The International Subarachnoid Aneurysm Trial (ISAT): A Position Statement from the Executive Committee of the American Society of Interventional and Therapeutic Neuroradiology and the
More informationProgress Review. Mervyn D.I. Vergouwen, MD, PhD; Rob J. de Haan, PhD; Marinus Vermeulen, MD, PhD; Yvo B.W.E.M. Roos, MD, PhD
Progress Review Effect of Statin Treatment on Vasospasm, Delayed Cerebral Ischemia, and Functional Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage A Systematic Review and Meta-Analysis Update
More informationLong term follow-up after endovascular treatment for intracranial aneurysms. Bart Emmer, MD, PhD
Long term follow-up after endovascular treatment for intracranial aneurysms Bart Emmer, MD, PhD Coiling 2 International Subarachnoid Aneurysm Trial Molyneux et al. Lancet Oct 26 2002 Clipping vs Coiling
More informationTHE EFFICACY AND SAFETY OF CILOSTAZOL IN SUBARACHNOID HEMORRHAGE. A META- ANALYSIS OF RANDOMIZED AND NON RANDOMIZED STUDIES DR. MUHAMMAD F.
THE EFFICACY AND SAFETY OF CILOSTAZOL IN SUBARACHNOID HEMORRHAGE. A META- ANALYSIS OF RANDOMIZED AND NON RANDOMIZED STUDIES DR. MUHAMMAD F. ISHFAQ ZEENAT QURESHI STROKE INSTITUTE AND UNIVERSITY OF TENNESSEE,
More informationDefinition พ.ญ.ส ธ ดา เย นจ นทร. Epidemiology. Definition 5/25/2016. Seizures after stroke Can we predict? Poststroke seizure
Seizures after stroke Can we predict? พ.ญ.ส ธ ดา เย นจ นทร PMK Epilepsy Annual Meeting 2016 Definition Poststroke seizure : single or multiple convulsive episode(s) after stroke and thought to be related
More informationClinical trial registration no.: NCT (clinicaltrials.gov) https://thejns.org/doi/abs/ / jns161301
CLINICAL ARTICLE J Neurosurg 128:120 125, 2018 Analysis of saccular aneurysms in the Barrow Ruptured Aneurysm Trial Robert F. Spetzler, MD, 1 Joseph M. Zabramski, MD, 1 Cameron G. McDougall, MD, 1 Felipe
More informationCorrelation of revised fisher scale with clinical
Research Article Correlation of revised fisher scale with clinical grading (WFNS) in patients with non-traumatic subarachnoid haemorrhage Basti Ram S. 1, Kumbar Vishwanath G. 2*, Nayak Madhukar T., Xavier
More informationThe presence of a severe, sudden headache, often referred
Sentinel Headache and the Risk of After Aneurysmal Subarachnoid Hemorrhage Jürgen Beck, MD; Andreas Raabe, MD, PhD; Andrea Szelenyi, MD; Joachim Berkefeld, MD, PhD; Rüdiger Gerlach, MD, PhD; Matthias Setzer,
More informationGuideline scope Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management
0 0 NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management The Department of Health and Social Care in England
More informationDifferent CT perfusion algorithms in the detection of delayed. cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage
Neuroradiology (2015) 57:469 474 DOI 10.1007/s00234-015-1486-8 DIAGNOSTIC NEURORADIOLOGY Different CT perfusion algorithms in the detection of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
More informationEndovascular treatment with coils has become an established
ORIGINAL RESEARCH S.P. Ferns C.B.L.M. Majoie M. Sluzewski W.J. van Rooij Late Adverse Events in Coiled Ruptured Aneurysms with Incomplete Occlusion at 6-Month Angiographic Follow-Up BACKGROUND AND PURPOSE:
More informationAndrew J Molyneux, Richard S C Kerr, Jacqueline Birks, Najib Ramzi, Julia Yarnold, Mary Sneade, Joan Rischmiller, for the ISAT collaborators
Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial
More informationTreatment of Acute Hydrocephalus After Subarachnoid Hemorrhage With Serial Lumbar Puncture
19 Treatment of Acute After Subarachnoid Hemorrhage With Serial Lumbar Puncture Djo Hasan, MD; Kenneth W. Lindsay, PhD, FRCS; and Marinus Vermeulen, MD Downloaded from http://ahajournals.org by on vember,
More informationLothian Audit of the Treatment of Cerebral Haemorrhage (LATCH)
1. INTRODUCTION Stroke physicians, emergency department doctors, and neurologists are often unsure about which patients they should refer for neurosurgical intervention. Early neurosurgical evacuation
More informationCoiling of ruptured and unruptured intracranial aneurysms
ORIGINAL RESEARCH W.J. van Rooij G.J. Keeren J.P.P. Peluso M. Sluzewski Clinical and Angiographic Results of Coiling of 196 Very Small (< 3 mm) Intracranial Aneurysms BACKGROUND AND PURPOSE: Coiling of
More informationImpact of a Protocol for Acute Antifibrinolytic Therapy on Aneurysm Rebleeding After Subarachnoid Hemorrhage
Impact of a Protocol for Acute Antifibrinolytic Therapy on Aneurysm Rebleeding After Subarachnoid Hemorrhage Robert M. Starke, BA; Grace H. Kim, MD; Andres Fernandez, MD; Ricardo J. Komotar, MD; Zachary
More informationIntracranial aneurysms are being treated with increasing frequency. Treatment of Poor-Grade Subarachnoid Hemorrhage Trial
Published July 24, 2014 as 10.3174/ajnr.A4061 ORIGINAL RESEARCH INTERVENTIONAL Treatment of Poor-Grade Subarachnoid Hemorrhage Trial D. Mitra, B. Gregson, V. Jayakrishnan, A. Gholkar, A. Vincent, P. White,
More informationClinical Analysis of Risk Factors Affecting Rebleeding in Patients with an Aneurysm. Gab Teug Kim, M.D.
/ 119 = Abstract = Clinical Analysis of Risk Factors Affecting Rebleeding in Patients with an Aneurysm Gab Teug Kim, M.D. Department of Emergency Medicine, College of Medicine, Dankook University, Choenan,
More informationIn patients with a symptomatic intracranial aneurysm,
De Novo Aneurysm Formation and Growth of Untreated Aneurysms A 5-Year MRA Follow-Up in a Large Cohort of Patients With Coiled Aneurysms and Review of the Literature Sandra P. Ferns, MD; Marieke E.S. Sprengers,
More informationThe incidence of subarachnoid hemorrhage (SAH) increases
ORIGINAL RESEARCH E.R. Gizewski S. Göricke A. Wolf B. Schoch D. Stolke M. Forsting I. Wanke Endovascular Treatment of Intracranial Aneurysms in Patients 65 Years or Older: Clinical Outcomes BACKGROUND
More informationSAH READMISSIONS TO NCCU
SAH READMISSIONS TO NCCU Are they preventable? João Amaral Rebecca Gorf Critical Care Outreach Team - NHNN 2015 Total admissions to NCCU =862 Total SAH admitted to NCCU= 104 (93e) (12.0%) Total SAH readmissions=
More informationTrigger factors for rupture of intracranial aneurysms in relation to patient and aneurysm characteristics
J Neurol (2012) 259:1298 1302 DOI 10.1007/s00415-011-6341-1 ORIGINAL COMMUNICATION Trigger factors for rupture of intracranial aneurysms in relation to patient and aneurysm characteristics Monique H. M.
More informationPredictors of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Cardiac Focus
Neurocrit Care (2010) 13:366 372 DOI 10.1007/s12028-010-9408-4 ORIGINAL ARTICLE Predictors of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Cardiac Focus Khalil Yousef Elizabeth
More informationA Less Invasive Approach for Ruptured Aneurysm with Intracranial Hematoma: Coil Embolization Followed by Clot Evacuation
A Less Invasive Approach for Ruptured Aneurysm with Intracranial Hematoma: Coil Embolization Followed by Clot Evacuation Je Hoon Jeong, MD 1 Jun Seok Koh, MD 1 Eui Jong Kim, MD 2 Index terms: Endovascular
More informationCanadian Best Practice Recommendations for Stroke Care 3.6 Acute Subarachnoid Hemorrhage
Last Updated: May 21, 2013 Canadian Best Practice Recommendations for Stroke Care Canadian Best Practice Recommendations for Stroke Care 2011-2013 Update Contents Search Strategy... 2 CSN Current Recommendations...Error!
More informationUltra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial
Germans et al. Trials 2013, 14:143 TRIALS STUDY PROTOCOL Open Access Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial Menno R Germans
More informationINTRODUCTION. O riginal A rticle. Singapore Med J 2013; 54(6): doi: /smedj
Singapore Med J 2013; 54(6): 332-338 doi: 10.11622/smedj.2013127 Management of ruptured intracranial aneurysms in the post-isat era: outcome of surgical clipping versus endovascular coiling in a Singapore
More informationManagement of Cerebral Aneurysms in Polycystic Kidney Disease. Dr H Stockley Consultant Neuroradiologist Greater Manchester Neuroscience Centre
Management of Cerebral Aneurysms in Polycystic Kidney Disease Dr H Stockley Consultant Neuroradiologist Greater Manchester Neuroscience Centre What is a cerebral aneurysm? Developmental degenerative arterial
More informationDept. of Neurosurgery, Division of Endovascular Neurosurgery, Medilaser Clinic, Tunja, Colombia 2
DOI: 10.17/sjmcr.01..1. Scholars Journal of Medical Case Reports Sch J Med Case Rep 01; (1):91-9 Scholars Academic and Scientific Publishers (SAS Publishers) (An International Publisher for Academic and
More informationQuantitative Analysis of Hemorrhage Volume for Predicting Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Quantitative Analysis of Hemorrhage Volume for Predicting Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Sang-Bae Ko, MD, PhD; H. Alex Choi, MD; Amanda Mary Carpenter, BA; Raimund Helbok, MD;
More informationPrognostic Factors for Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage
Prognostic Factors for Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage Axel J. Rosengart, MD, PhD; Kim E. Schultheiss, MD, MS; Jocelyn Tolentino, MA; R. Loch Macdonald, MD, PhD Background and
More informationNeurointensive Care of Aneurysmal Subarachnoid Hemorrhage. Alejandro A. Rabinstein Department of Neurology Mayo Clinic, Rochester, USA
Neurointensive Care of Aneurysmal Subarachnoid Hemorrhage Alejandro A. Rabinstein Department of Neurology Mayo Clinic, Rochester, USA The traditional view: asah is a bad disease Pre-hospital mortality
More informationSubarachnoid hemorrhage secondary to ruptured intracranial
CHAPTER 20 Long-term Angiographic and Clinical Outcomes in Completely Versus Incompletely Coiled Ruptured Intracranial Aneurysms Michael K. Tso, MD, Puneet Kochar, MD, Mayank Goyal, MD, Mark E. Hudon,
More informationShaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA.
Shobana Rajan, M.D. Staff Anesthesiologist, Cleveland Clinic, Cleveland, Ohio Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA. This
More informationLong-term MRA follow-up after coiling of intracranial aneurysms: impact on mood and anxiety
Neuroradiology (2011) 53:343 348 DOI 10.1007/s00234-010-0726-1 INTERVENTIONAL NEURORADIOLOGY Long-term MRA follow-up after coiling of intracranial aneurysms: impact on mood and anxiety Sandra P. Ferns
More informationShort-term Tranexamic Acid Treatment in Aneurysmal Subarachnoid Hemorrhage
4 Short-term Tranexamic Acid Treatment in Aneurysmal Subarachnoid Hemorrhage Eelco F.M. Wijdicks, MD, Djo Hasan, MD, Kenneth W. Lindsay, PhD, FRCS, Paul J.A.M. Brouwers, MD, Richard Hatfield, FRCS, Gordon
More informationPATRICK MITCHELL, F.R.C.S., 1 RICHARD KERR, F.R.C.S., 2 A. DAVID MENDELOW, F.R.C.S., 1 AND ANDY MOLYNEUX, F.R.C.R., 2
See the Editorials in this issue, pp 433 436. J Neurosurg 108:437 442, 2008 Could late rebleeding overturn the superiority of cranial aneurysm coil embolization over clip ligation seen in the International
More informationCoiling of Very Large or Giant Cerebral Aneurysms: Long-Term Clinical and Serial Angiographic Results
AJNR Am J Neuroradiol 24:257 262, February 2003 Coiling of Very Large or Giant Cerebral Aneurysms: Long-Term Clinical and Serial Angiographic Results Menno Sluzewski, Tomas Menovsky, Willem Jan van Rooij,
More informationRecombinant Factor VIIa for Intracerebral Hemorrhage
Recombinant Factor VIIa for Intracerebral Hemorrhage January 24, 2006 Justin Lee Pharmacy Resident University Health Network Outline 1. Introduction to patient case 2. Overview of intracerebral hemorrhage
More informationLong-term effects of antiplatelet drugs on aneurysm occlusion after endovascular treatment
1 Department of Neurosurgery, Goethe University, Frankfurt, Germany 2 Department of Neuroradiology, Goethe University, Frankfurt, Germany Correspondence to Dr Johannes Platz, Department of Neurosurgery,
More informationThe standard examination to evaluate for a source of subarachnoid
Published April 11, 2013 as 10.3174/ajnr.A3478 ORIGINAL RESEARCH INTERVENTIONAL Use of CT Angiography and Digital Subtraction Angiography in Patients with Ruptured Cerebral Aneurysm: Evaluation of a Large
More informationAneurysmal subarachnoid hemorrhage (SAH) used to be
Excess Mortality and Cardiovascular Events in Patients Surviving Subarachnoid Hemorrhage A Nationwide Study in Sweden Dennis J. Nieuwkamp, MD; Ale Algra, MD; Paul Blomqvist, MD, PhD; Johanna Adami, MD,
More informationPerils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion
Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion Aman B. Patel, MD Robert & Jean Ojemann Associate Professor Director, Cerebrovascular Surgery Director, Neuroendovascular
More informationFrom interventional cardiology to cardio-neurology. A new subspeciality
From interventional cardiology to cardio-neurology. A new subspeciality in the future? Prof. Andrejs Erglis, MD, PhD Pauls Stradins Clinical University Hospital University of Latvia Riga, LATVIA Disclosure
More informationSub-arachnoid haemorrhage
Sub-arachnoid haemorrhage Dr Mary Newton Consultant Anaesthetist The National Hospital for Neurology and Neurosurgery UCL Hospitals NHS Trust mary.newton@uclh.nhs.uk Kiev, Ukraine September 17 th 2009
More informationPrognostic Significance of Hyponatremia Leukocytosis, Hypomagnesemia, and Fever after Aneurysmal Subarachnoid Hemorrhage
THIEME Original Article 69 Prognostic Significance of Hyponatremia Leukocytosis, Hypomagnesemia, and Fever after Aneurysmal Subarachnoid Hemorrhage Vrsajkov Vladimir 1 Jovanović Gordana 2 Galešev Marija
More informationContents. Version 1.0: 01/02/2010 Protocol# ISRCTN Page 1 of 7
Contents 1. INTRODUCTION... 2 2. STUDY SYNOPSIS... 2 3. STUDY OBJECTIVES... 2 3.1. Primary Objective... 2 3.2. Secondary Objectives... 2 3.3. Assessment of Objectives... 3 3.4. Change the Primary Objective
More informationDepartment of Intensive Care Medicine, University Hospital (Inselspital) and University of Bern, Switzerland
clinical article J Neurosurg 122:408 413, 2015 Impact of early-onset seizures on grading and outcome in patients with subarachnoid hemorrhage Christian Fung, MD, 1 Mathias Balmer, MD, 1 Michael Murek,
More informationClinical manifestations, diagnosis and medical management of
Clinical manifestations, diagnosis and medical management of aneurysmal SAH David Bervini, MD MAdvSurg Department of Neurosurgery Inselspital University of Bern Switzerland 1 2 3 Aneurysmal SAH Incidence:
More informationWhat You Should Know About Cerebral Aneurysms
American Society of Neuroradiology American Society of Interventional & Therapeutic Neuroradiology What You Should Know About Cerebral Aneurysms From the Cerebrovascular Imaging and Intervention Committee
More informationWHITE PAPER: A GUIDE TO UNDERSTANDING SUBARACHNOID HEMORRHAGE
WHITE PAPER: A GUIDE TO UNDERSTANDING SUBARACHNOID HEMORRHAGE Subarachnoid Hemorrhage is a serious, life-threatening type of hemorrhagic stroke caused by bleeding into the space surrounding the brain,
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Medical technology guidance SCOPE Pipeline embolisation device for the treatment of
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Medical technology guidance SCOPE Pipeline embolisation device for the treatment of 1 Technology complex intracranial aneurysms 1.1 Description of
More informationIt is well known that cerebral aneurysms are surprisingly
Controversies in Stroke Section Editors: Geoffrey A. Donnan, MD, FRACP, and Stephen M. Davis, MD, FRACP Patients With Small, Asymptomatic, Unruptured Hemorrhage Should Be Treated Conservatively Geoffrey
More informationAneurysms of the posterior inferior cerebellar artery
ORIGINAL RESEARCH J.P. Peluso W.J. van Rooij M. Sluzewski G.N. Beute C.B. Majoie Posterior Inferior Cerebellar Artery Aneurysms: Incidence, Clinical Presentation, and Outcome of Endovascular Treatment
More informationMulti-modality management of intracranial aneurysms
Multi-modality management of intracranial aneurysms Christopher Koebbe, Maj, USAF, MC Staff Neurosurgeon San Antonio Military Medical Consortium Clinical Assistant Professor Department of Neurological
More informationIntra-arterial nimodipine for the treatment of vasospasm due to aneurysmal subarachnoid hemorrhage
Romanian Neurosurgery (2016) XXX 4: 461 466 461 DOI: 10.1515/romneu-2016-0074 Intra-arterial nimodipine for the treatment of vasospasm due to aneurysmal subarachnoid hemorrhage A. Chiriac, Georgiana Ion*,
More informationLong-Term Excess Mortality After Aneurysmal Subarachnoid Hemorrhage Patients With Multiple Aneurysms at Risk
Long-Term Excess Mortality After Aneurysmal Subarachnoid Hemorrhage Patients With Multiple Aneurysms at Risk Justiina Huhtakangas, MD; Hanna Lehto, MD; Karri Seppä, MSc, PhD; Riku Kivisaari, MD, PhD; Mika
More informationSliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials
See the corresponding editorial in this issue, pp 1 2. J Neurosurg 118:3 12, 2013 AANS, 2013 Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials
More informationAneurysmal subarachnoid hemorrhage in the elderly:
Aneurysmal subarachnoid hemorrhage in the elderly: Helsinki experience 1980-2008 Eljas Supponen, BM Student number: 013302559 Helsinki 04.05.2012 Thesis eljas.supponen@helsinki.fi Supervisors: Martin Lehecka,
More informationWhen determining the management strategy for a
clinical article J Neurosurg 122:383 391, 2015 Formal protocol for emergency treatment of ruptured intracranial aneurysms to reduce in-hospital rebleeding and improve clinical outcomes Jaechan Park, MD,
More informationPreoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage
CLINICAL ARTICLE J Neurosurg 126:1764 1771, 2017 Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage *Bing Zhao,
More informationTreatment of Unruptured Vertebral Artery Dissecting Aneurysms
33 Treatment of Unruptured Vertebral Artery Dissecting Aneurysms Isao NAITO, M.D., Shin TAKATAMA, M.D., Naoko MIYAMOTO, M.D., Hidetoshi SHIMAGUCHI, M.D., and Tomoyuki IWAI, M.D. Department of Neurosurgery,
More informationBecause of its occurrence at young age and its often poor
Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage A Randomized Controlled Trial Walter M. van den Bergh; on behalf of the MASH Study Group Background and Purpose Magnesium reverses cerebral vasospasm
More informationStroke Treatment Beyond Traditional Time Windows. Rishi Gupta, MD, MBA
Stroke Treatment Beyond Traditional Time Windows Rishi Gupta, MD, MBA Director, Stroke and Neurocritical Care Endovascular Neurosurgery Wellstar Health System THE PAST THE PRESENT 2015 American Heart Association/American
More informationDelayed cerebral ischemia (DCI) is an important cause for
Prognostic Value of Cerebral Perfusion Computed Tomography in the Acute Stage After Subarachnoid Hemorrhage for the Development of Delayed Cerebral Ischemia Irene van der Schaaf, MD; Marieke J. Wermer,
More informationEndovascular treatment is now the preferred treatment option
ORIGINAL RESEARCH P.M. White S.C. Lewis H. Nahser R.J. Sellar T. Goddard A. Gholkar on behalf of the HELPS Trial Collaboration HydroCoil Endovascular Aneurysm Occlusion and Packing Study (HELPS Trial):
More informationlek Magdalena Puławska-Stalmach
lek Magdalena Puławska-Stalmach tytuł pracy: Kliniczne i radiologiczne aspekty tętniaków wewnątrzczaszkowych a wybór metody leczenia Summary An aneurysm is a localized, abnormal distended lumen of the
More informationAneurysmal Neck Clipping as the Primary Treatment Option for Both Ruptured and Unruptured Middle Cerebral Artery Aneurysms
www.jkns.or.kr http://dx.doi.org/10.3340/jkns.2016.59.3.269 J Korean Neurosurg Soc 59 (3) : 269-275, 2016 Print ISSN 2005-3711 On-line ISSN 1598-7876 Copyright 2016 The Korean Neurosurgical Society Clinical
More informationNEUROSURGICAL EMERGENCY GUIDELINE DEVELOPMENT GROUP P3 NEURO CENTER OF NEUROSCIENCE RESEARCH AND SERVICE USM
NEUROSURGICAL EMERGENCY GUIDELINE DEVELOPMENT GROUP P3 NEURO CENTER OF NEUROSCIENCE RESEARCH AND SERVICE USM Chairperson Professor Dr Zamzuri Idris Head of Department Members Associate Professor Dato Dr
More informationAge-Associated Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Age-Associated Vasospasm in Aneurysmal Subarachnoid Hemorrhage Sushant P. Kale, MD, MPH,* Randall C. Edgell, MD,* Amer Alshekhlee, MD,* Afshin Borhani Haghighi, MD,* Justin Sweeny, MD, Jason Felton, MD,
More informationSubarachnoid Hemorrhage (SAH) Disclosures/Relationships. Click to edit Master title style. Click to edit Master title style.
Subarachnoid Hemorrhage (SAH) William J. Jones, M.D. Assistant Professor of Neurology Co-Director, UCH Stroke Program Click to edit Master title style Disclosures/Relationships No conflicts of interest
More informationEndovascular Treatment of Cerebral Arteriovenous Malformations. Bs. Nguyễn Ngọc Pi Doanh- Bs Đặng Ngọc Dũng Khoa Ngoại Thần Kinh
Endovascular Treatment of Cerebral Arteriovenous Malformations Bs. Nguyễn Ngọc Pi Doanh- Bs Đặng Ngọc Dũng Khoa Ngoại Thần Kinh Stroke Vascular Malformations of the Brain Epidemiology: - Incidence: 0.1%,
More informationClinical Review of 20 Cases of Terson s Syndrome
34 Clinical Review of 20 Cases of Terson s Syndrome Takashi SUGAWARA, M.D., Yoshio TAKASATO, M.D., Hiroyuki MASAOKA, M.D., Yoshihisa OHTA, M.D., Takanori HAYAKAWA, M.D., Hiroshi YATSUSHIGE, M.D., Shogo
More informationA discussion of the optimal treatment of intracranial aneurysm rupture in elderly patients
A discussion of the optimal treatment of intracranial aneurysm rupture in elderly patients C. Liu Neurology Department, The Central Hospital of Luoyang Affiliated to Zhengzhou University, Luoyang City,
More informationThe Worst Headache of My Life Hemorrhagic Stroke
The Worst Headache of My Life Hemorrhagic Stroke Lindsay Trantum ACNP-BC Neurocritical Care Nurse Practitioner Assistant in Anesthesiology, Division of Critical Care Objectives Identify the risk factors
More informationNoninvasive Methods of Neurovisualization in the Diagnostics of Secondary Ischemia at Nontraumatic Intracranial Hemorrhages
American Journal of Medicine and Medical Sciences 2019, 9(1): 2-4 DOI: 10.592/j.ajmms.20190901.05 Noninvasive Methods of Neurovisualization in the Diagnostics of Secondary Ischemia at Nontraumatic Intracranial
More informationRedgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on
6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor
More informationEndovascular Treatment for Acute Ischemic Stroke
ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1
More informationSpontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke
Original Contribution Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke Abstract Introduction: Acute carotid artery occlusion carries
More informationBath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN (In Press)
Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN 0140-6736 (In Press) Access from the University of Nottingham repository: http://eprints.nottingham.ac.uk/1087/1/lancet_clots_1_20090522_4.pdf
More informationACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke
ACUTE ISCHEMIC STROKE Current Treatment Approaches for Acute Ischemic Stroke EARLY MANAGEMENT OF ACUTE ISCHEMIC STROKE Rapid identification of a stroke Immediate EMS transport to nearest stroke center
More informationEndovascular coil embolization of ruptured intracranial. The Barrow Ruptured Aneurysm Trial. Clinical article
See the corresponding editorial, DOI: 10.3171/2011.6.JNS11625. DOI: 10.3171/2011.8.JNS101767 The Barrow Ruptured Aneurysm Trial Clinical article Cameron G. McDougall, M.D., 1 Robert F. Spetzler, M.D.,
More informationThe Relationship between Clinical Outcome in Subarachnoidal Hemorrhage Patients with Emergency Medical Service Usage and Interhospital Transfer
ORIGINAL ARTICLE Emergency & Critical Care Medicine http://dx.doi.org/10.3346/jkms.2015.30.12.1889 J Korean Med Sci 2015; 30: 1889-1895 The Relationship between Clinical Outcome in Subarachnoidal Hemorrhage
More informationBrain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage
Cronicon OPEN ACCESS EC PAEDIATRICS Case Report Brain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage Dimitrios Panagopoulos* Neurosurgical Department, University
More information